Aurora Cannabis (TSE:ACB) Trading Up 0.8% – Time to Buy?

Aurora Cannabis Inc. (TSE:ACB) shares shot up 0.8% during trading on Tuesday . The company traded as high as C$4.01 and last traded at C$3.91. 677,940 shares traded hands during trading, an increase of 71% from the average session volume of 395,573 shares. The stock had previously closed at C$3.88.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ACB. TD cut their price objective on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating on the stock in a report on Friday, June 12th. Canaccord Genuity Group lowered their target price on Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating for the company in a research note on Tuesday, June 30th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of C$7.17.

Aurora Cannabis Stock Up 0.8%

The firm has a market capitalization of C$242.19 million, a P/E ratio of -1.83 and a beta of 0.27. The company has a debt-to-equity ratio of 4.66, a quick ratio of 2.48 and a current ratio of 5.94. The firm’s 50-day moving average is C$4.13 and its 200 day moving average is C$4.66.

Aurora Cannabis (TSE:ACB) last released its earnings results on Thursday, June 11th. The company reported C($0.99) earnings per share (EPS) for the quarter. The firm had revenue of C$38.01 million for the quarter. Aurora Cannabis had a negative return on equity of 7.25% and a negative net margin of 12.13%. As a group, equities research analysts predict that Aurora Cannabis Inc. will post -0.22 EPS for the current fiscal year.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.